Ra Medical Systems, Inc.
RMED · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 6.6% | 48.3% | 53.8% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 92% | 93.4% | 92.3% | 93.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3 | $3 | $3 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $2 | $0 | $0 |
| Operating Expenses | $3 | $5 | $4 | $3 |
| Operating Income | -$3 | -$5 | -$4 | -$48 |
| % Margin | -1,336.7% | -2,203.8% | -2,492.3% | -51,512.9% |
| Other Income/Exp. Net | $1 | -$2 | -$1 | $104 |
| Pre-Tax Income | -$2 | -$6 | -$5 | $56 |
| Tax Expense | -$0 | -$1 | -$1 | $2 |
| Net Income | -$2 | -$5 | -$4 | $49 |
| % Margin | -996% | -2,409.9% | -2,828.7% | 52,582.8% |
| EPS | -1.7 | -0.38 | -0.36 | 18.54 |
| % Growth | -347.4% | -5.6% | -101.9% | – |
| EPS Diluted | -1.7 | -0.38 | -0.36 | 18.54 |
| Weighted Avg Shares Out | 13 | 13 | 11 | 3 |
| Weighted Avg Shares Out Dil | 13 | 13 | 11 | 3 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | -$0 |
| Interest Expense | $0 | $0 | $0 | -$0 |
| Depreciation & Amortization | $1 | $0 | $0 | -$2 |
| EBITDA | -$2 | -$5 | -$4 | $50 |
| % Margin | -753.5% | -2,203.8% | -2,492.3% | 53,360.8% |